How your lifestyle switches your genes on and off
Your DNA doesn’t change, but the way your genes are read does. A new review in Science maps how epigenetic changes — driven by diet, stress, and environment — shape long-term health…
Epigenetics is the study of how genes are switched on and off without any change to the underlying DNA sequence. Small chemical tags — methyl groups, acetyl groups — attach to DNA or to the proteins around which it is wrapped, and determine whether a gene is active or silenced. These tags are not fixed: they respond to what you eat, how much you exercise, the stress you experience, and even to the experiences of your parents and grandparents. The implications of that responsiveness are broader than biologists imagined for much of the twentieth century.
The paper, published in Science in April 2026, examines how epigenetic changes not only contribute to disease but also explain functional decline and disability in later life — a connection that had received relatively little systematic attention. The review brings together evidence from multiple research areas to argue that epigenetic mechanisms sit at the intersection of aging, environment, and health outcomes.
It’s not just what you inherit
One of the study’s central points is that epigenetic patterns accumulate and amplify across a lifetime. Early exposure to stress, poor nutrition during development, or environmental toxins can leave epigenetic marks that only manifest as disease or accelerated biological aging decades later. Biological age — measured through so-called epigenetic clocks such as the Horvath clock or GrimAge — can diverge substantially from chronological age, depending on lifestyle and environment. Some people in their fifties show the biological signatures of someone a decade older; others the reverse.
This makes epigenetics relevant for both prevention and treatment. In principle, epigenetic changes are reversible: modify the chemical tags, and gene expression can potentially be restored. Drugs that target epigenetic enzymes — HDAC inhibitors and DNA methylation inhibitors — are already used in oncology. The question is whether comparable approaches could work for age-related conditions beyond cancer.
The gap between promise and proof
Caution is warranted. Much of the research linking epigenetics to aging remains observational: correlations between epigenetic patterns and health outcomes are clear, but causal evidence is harder to establish. For lifestyle interventions — regular exercise, dietary changes, stress reduction — there is evidence of favorable effects on epigenetic markers, but the clinical translation of those findings lags behind the theoretical framework.
The Science review is, in this sense, a call for more longitudinal research: studies that follow people over decades, combining detailed epigenetic measurements with outcomes in health and function. Without that data, epigenetics remains a compelling story — one whose practical consequences we are only beginning to map.